[PHARMA] QoQ Annualized Quarter Result on 30-Jun-2018 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
17-Aug-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
30-Jun-2018 [#2]
Profit Trend
QoQ- -34.66%
YoY- -19.21%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Revenue 3,144,432 2,384,956 2,384,416 2,401,304 2,471,692 2,323,960 2,281,018 23.88%
PBT 120,972 70,220 77,706 81,354 114,828 73,064 70,930 42.79%
Tax -42,380 -26,990 -26,160 -34,644 -44,472 -17,977 -27,065 34.88%
NP 78,592 43,230 51,546 46,710 70,356 55,087 43,865 47.56%
-
NP to SH 78,468 42,468 50,708 45,960 70,344 53,823 42,697 50.09%
-
Tax Rate 35.03% 38.44% 33.67% 42.58% 38.73% 24.60% 38.16% -
Total Cost 3,065,840 2,341,726 2,332,869 2,354,594 2,401,336 2,268,873 2,237,153 23.40%
-
Net Worth 528,825 509,862 522,618 519,642 524,838 526,888 531,892 -0.38%
Dividend
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Div 62,521 41,621 48,535 46,767 51,964 49,314 44,973 24.58%
Div Payout % 79.68% 98.01% 95.71% 101.76% 73.87% 91.62% 105.33% -
Equity
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Net Worth 528,825 509,862 522,618 519,642 524,838 526,888 531,892 -0.38%
NOSH 260,505 260,505 260,505 259,821 259,821 259,821 259,821 0.17%
Ratio Analysis
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
NP Margin 2.50% 1.81% 2.16% 1.95% 2.85% 2.37% 1.92% -
ROE 14.84% 8.33% 9.70% 8.84% 13.40% 10.22% 8.03% -
Per Share
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
RPS 1,207.05 916.82 917.05 924.21 951.31 895.38 879.14 23.55%
EPS 30.12 16.33 19.51 17.68 27.08 20.74 16.45 49.72%
DPS 24.00 16.00 18.67 18.00 20.00 19.00 17.33 24.26%
NAPS 2.03 1.96 2.01 2.00 2.02 2.03 2.05 -0.65%
Adjusted Per Share Value based on latest NOSH - 259,821
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
RPS 218.17 165.48 165.44 166.61 171.50 161.25 158.27 23.88%
EPS 5.44 2.95 3.52 3.19 4.88 3.73 2.96 50.09%
DPS 4.34 2.89 3.37 3.24 3.61 3.42 3.12 24.63%
NAPS 0.3669 0.3538 0.3626 0.3605 0.3642 0.3656 0.369 -0.38%
Price Multiplier on Financial Quarter End Date
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Date 29/03/19 31/12/18 28/09/18 29/06/18 30/03/18 29/12/17 29/09/17 -
Price 2.27 2.78 2.89 2.88 4.28 4.60 4.14 -
P/RPS 0.19 0.30 0.32 0.31 0.45 0.51 0.47 -45.35%
P/EPS 7.54 17.03 14.82 16.28 15.81 22.18 25.16 -55.25%
EY 13.27 5.87 6.75 6.14 6.33 4.51 3.97 123.72%
DY 10.57 5.76 6.46 6.25 4.67 4.13 4.19 85.41%
P/NAPS 1.12 1.42 1.44 1.44 2.12 2.27 2.02 -32.53%
Price Multiplier on Announcement Date
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Date 16/05/19 21/02/19 19/11/18 17/08/18 16/05/18 27/02/18 15/11/17 -
Price 2.36 2.76 3.09 3.11 4.07 4.04 3.82 -
P/RPS 0.20 0.30 0.34 0.34 0.43 0.45 0.43 -39.99%
P/EPS 7.83 16.91 15.84 17.58 15.03 19.48 23.21 -51.57%
EY 12.76 5.92 6.31 5.69 6.65 5.13 4.31 106.31%
DY 10.17 5.80 6.04 5.79 4.91 4.70 4.54 71.28%
P/NAPS 1.16 1.41 1.54 1.56 2.01 1.99 1.86 -27.02%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment